Hovnanian Enterprises Inc
HOV NYSE Operative Builders Financials FY2016βFY2025
What Hovnanian Enterprises Inc does
No business description yet.
- Legal name
- HOVNANIAN ENTERPRISES INC
- Fiscal year ends
- October 31, 2025
- Latest annual report
- 10-K Β· Dec 22, 2025
- Accession Β· CIK
- 0001753926-25-001938
0000357294
Revenue and margins
Hovnanian Enterprises Inc had $3.0B of revenue in fiscal 2025, down 0.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $166M in fiscal 2025, 5.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hovnanian Enterprises Inc returned $40.9M to shareholders in fiscal 2025, 25% of free cash flow. The diluted share count fell 1.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hovnanian Enterprises Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Debt incl. finance leases | $1.2B | $1.1B | $1.1B | $896M | $901M |
| Debt / equity | 7.1x | 3.0x | 1.8x | 1.1x | 1.1x |
| Total assets | $2.3B | $2.6B | $2.5B | $2.6B | $2.6B |
| Total liabilities | $2.1B | $2.2B | $1.9B | $1.8B | $1.8B |
| Shareholders' equity | $175M | $383M | $582M | $800M | $831M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 2 / 7 | 2 / 7 | 6 / 7 | 5 / 7 | 3 / 7 | 5 / 7 | 5 / 7 | 5 / 7 |
| Accruals ratio | β16.6% | β29.8% | 4.0% | 11.7% | β13.0% | 19.2% | 5.6% | β9.1% | 8.6% | β4.7% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.8B | $2.5B | $2.0B | $2.0B | $2.3B | $2.8B | $2.9B | $2.8B | $3.0B | $3.0B |
| Provision for credit losses | $0.3M | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | β | β |
| Interest expense | $183M | $185M | $164M | $161M | $178M | $162M | $132M | $135M | $121M | β |
| Pretax income | $2.4M | β$45.2M | $8.1M | β$39.7M | $55.4M | $190M | $320M | $256M | $317M | $86.1M |
| Income tax | $5.3M | $287M | $3.6M | $2.4M | $4.5M | β$418M | $94.3M | $50.1M | $75.1M | $22.2M |
| Net income | β$2.8M | β$332M | $4.5M | β$42.1M | $50.9M | $608M | $225M | $206M | $242M | $63.9M |
| Net income to common | β$2.8M | β$332M | $4.4M | β$42.1M | $46.3M | $550M | $195M | $179M | $223M | $51.2M |
| Diluted EPS | β$0.02 | β$56.23 | $0.72 | β$7.06 | $7.03 | $85.86 | $29.00 | $26.88 | $31.79 | $7.43 |
| Diluted shares | 0.15B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $387M | $302M | β$66.8M | β$249M | $293M | $210M | $89.5M | $435M | $23.6M | $188M |
| Capital expenditure | $8.0M | $6.5M | $5.2M | $4.0M | $3.4M | $5.9M | $12.6M | $18.8M | $17.9M | $22.1M |
| Free cash flow | $379M | $295M | β$72.0M | β$253M | $289M | $204M | $76.9M | $416M | $5.8M | $166M |
| Depreciation and amortization | $3.6M | $4.2M | $3.2M | $4.2M | $5.3M | $5.3M | $5.5M | $8.8M | $7.7M | $13.9M |
| Stock-based compensation | $2.9M | $0.6M | $3.7M | $0.7M | $2.8M | $7.7M | $10.3M | $14.2M | $25.3M | $16.7M |
| Share buybacks | β | β | β | β | $0.0M | $0.0M | $12.2M | $4.8M | $26.5M | $30.2M |
| Dividends paid | β | β | β | $0.0M | $0.0M | $0.0M | $10.7M | $10.7M | $10.7M | $10.7M |
| Dividends and buybacks | β | β | β | $0.0M | $0.0M | $0.0M | $22.9M | $15.5M | $37.2M | $40.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $347M | $469M | β | β | β | β | β | β | β | β |
| Total debt | $1.6B | $1.6B | $1.4B | $1.5B | $1.4B | $1.2B | $1.1B | $1.1B | $896M | $901M |
| Property and equipment, net | $50.3M | $52.9M | $20.3M | $20.1M | $18.2M | $18.7M | $25.8M | $33.9M | $43.4M | $50.5M |
| Total assets | $2.4B | $1.9B | $1.7B | $1.9B | $1.8B | $2.3B | $2.6B | $2.5B | $2.6B | $2.6B |
| Total liabilities | $2.5B | $2.4B | $2.1B | $2.4B | $2.3B | $2.1B | $2.2B | $1.9B | $1.8B | $1.8B |
| Preferred stock | $135M | $135M | $135M | $135M | $135M | $135M | $135M | $135M | $135M | $135M |
| Shareholders' equity | β$129M | β$460M | β$454M | β$490M | β$437M | $175M | $383M | $582M | $800M | $831M |
| Margins | ||||||||||
| Net margin | β0.1% | β13.5% | 0.2% | β2.1% | 2.2% | 21.8% | 7.7% | 7.5% | 8.1% | 2.1% |
| FCF margin | 13.8% | 12.0% | β3.6% | β12.6% | 12.3% | 7.3% | 2.6% | 15.1% | 0.2% | 5.6% |
| Returns | ||||||||||
| Return on equity | β | β | β | β | β | β | 80.8% | 42.7% | 35.0% | 7.8% |
| Return on assets | β0.1% | β15.6% | 0.3% | β2.4% | 2.7% | 29.3% | 9.2% | 8.1% | 9.5% | 2.4% |
| Return on tangible equity | β | β | β | β | β | 314.6% | 50.9% | 30.8% | 27.8% | 6.2% |
| Growth | ||||||||||
| Revenue growth | β | β10.9% | β18.8% | 1.3% | 16.2% | 18.7% | 5.0% | β5.7% | 9.0% | β0.9% |
| Net income growth | β | β | β | β1,031.8% | β | 1,093.5% | β62.9% | β8.7% | 17.5% | β73.6% |
| EPS growth | β | β | β | β1,080.6% | β | 1,121.3% | β66.2% | β7.3% | 18.3% | β76.6% |
| FCF growth | β | β22.1% | β124.4% | β | β | β29.4% | β62.4% | 441.7% | β98.6% | 2,774.6% |
| Share count change | β | β96.0% | 2.8% | β1.7% | 10.3% | β2.9% | 5.2% | β0.9% | 5.1% | β1.6% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | β | 7.1x | 3.0x | 1.8x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.3% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% | 0.4% | 0.7% | 0.6% | 0.7% |
| Stock comp / revenue | 0.1% | 0.0% | 0.2% | 0.0% | 0.1% | 0.3% | 0.4% | 0.5% | 0.8% | 0.6% |
| Payouts / FCF | β | β | β | β | 0.0% | 0.0% | 29.8% | 3.7% | 644.0% | 24.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 2.0 | 2.0 | 6.0 | 5.0 | 3.0 | 5.0 | 5.0 | 5.0 |
| Accruals ratio | β16.6% | β29.8% | 4.0% | 11.7% | β13.0% | 19.2% | 5.6% | β9.1% | 8.6% | β4.7% |
Source: SEC EDGAR XBRL filings (CIK 0000357294). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.